INSIGHTS ON CLINICAL TRIAL DESIGN
-
Why Tax Reporting Matters In Clinical Trial Participant Payments
Clinical trial participant payments can trigger often overlooked tax reporting obligations. Learn why early visibility into payments matters and how better tracking helps avoid compliance surprises.
-
Your Biggest Unblinding Risk? Inexperienced Staff
Protect study integrity by closing the gaps in IRT workflows. Learn why rushed communication and training lapses lead to accidental unblinding and how to safeguard your clinical data.
-
Virtual Clinical Trials For Ophthalmic Measures
Remote ophthalmic assessments such as BCVA, OCT, and IOP expand trial access and efficiency, preserving data quality while reducing site burden and boosting patient engagement.
-
Endpoint Clinical RTSM: Getting The Job Done
Explore how a Job-to-be-Done (JTBD)-focused RTSM approach reduces delays, optimizes costs, and accelerates trial success through predictive intelligence and streamlined global workflows.
-
Breaking Barriers In Drug Development: Time, Trust And Putting Patients First1/16/2025
Unpack systemic challenges in drug development that inflate costs and delay life-saving treatments. Learn about streamlining processes, fostering patient trust, and reallocating resources efficiently.
-
De-Risking The Neurology IND: Lessons From Early FDA Engagement5/27/2026
Learn how early FDA alignment can help your neurology program move forward with greater clarity, confidence, and regulatory readiness.
-
The New Era Of Evidence Generation In Clinical Trials6/19/2024
Learn how top pharmaceutical companies are using novel innovations to drive greater speed, scale, and access in clinical research than ever before in this webinar hosted by Musaddiq Khan, Vice President of DCT Solutions at Medable.
-
Critical Inputs For Configuring An RTSM3/25/2026
Uncover why clearly defined visit schedules and dispensing events are essential in RTSM design — and how resolving protocol ambiguity early prevents downstream complexity across systems and sites.
-
Accelerate Your Oncology Breakthroughs4/16/2025
Finding the right partnership can help your oncology clinical trials overcome trial complexities through strategic planning, a deep scientific understanding, and operational excellence.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Metabolic and endocrine diseases are a rising therapy area focus for clinical research due to the high demand for novel therapies that are challenged with proving safety and efficacy.
-
CSSi offers unmatched depth and breadth in therapeutic expertise, providing full-spectrum, in-house capabilities, positing the organization as a true end-to-end partner in clinical trials.
-
Citeline Study Feasibility is a platform that combines subject-matter expertise and machine learning to develop predictive insights for feasibility planning. Clinical trial sponsors can use these insights to identify key data drivers and model their impact, build and simulate feasibility scenarios, accelerate timelines, and make better decisions than with statistical methods alone.
-
Integrate sensors into your study to evaluate digital endpoints with a comprehensive solution that accelerates drug development, reduces patient sample sizes, cuts costs, and improves patient insights.
-
Leverage our extensive expertise across over 120 therapeutic indications to drive your success.